• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10
    • Buyers' Guide
    • Events
    • Microsites
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10
  • Buyers' Guide
  • Events
  • Microsites
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    Top Features
    Development Options: Orthopedic Device Design

    I, Surgical Robot

    Printer-Friendly: An Additive Manufacturing Update

    Instrumentation Innovations: A Review of Instrument Manufacturing

    The Total Package: Packaging and Sterilization for Orthopedics
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    Orthopedic Innovators
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    Biogennix Rolls Out Agilon Strip Bone Graft

    Global Bone Tumor Ablation Devices Market to Top $111 Million by 2027

    GreenBone Ortho Closes 10 Million Euros Series B Funding Round

    SynerFuse, Cirtec Medical Partner to Develop Back Pain Management Device

    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    Incorporate Packaging, Sterilization Early in Product Design to Avoid Costly Mistakes

    SynerFuse, Cirtec Medical Partner to Develop Back Pain Management Device

    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury

    HSS and LimaCorporate Open Provider-Based 3D Design and Printing Facility

    Usability, Sustainability Becoming More Relevant in Medtech Packaging
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Incorporate Packaging, Sterilization Early in Product Design to Avoid Costly Mistakes

    Usability, Sustainability Becoming More Relevant in Medtech Packaging

    Orthopedic Solutions from Man’s Best Friend

    The FDA’s Flip-Flop on Hyaluronic Acid

    HSS, Zimmer Biomet's Solution for the Episode of Orthopedic Care
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    Lincotek Medical

    Edge International/Supra Alloys

    NN Life Sciences/Paragon Medical

    Tecomet

    Structure Medical
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Online Exclusives

    Academia: The Main Innovation Source for Orthobiologics

    Smith+Nephew has formed a Biologics and Regenerative Medicine R&D team dedicated to development of innovative orthobiologic products.

    Academia: The Main Innovation Source for Orthobiologics
    Smith+Nephew's GrafixPL PRIME (after rehydration) is a lyopreserved placental amniotic membrane designed for application directly to acute and chronic wounds. Image courtesy of Smith+Nephew.
    Related CONTENT
    • GreenBone Ortho Closes 10 Million Euros Series B Funding Round
    • SeaSpine to Acquire 7D Surgical for $110M
    • Surgalign Launches New Device for Bone Formation
    • Locate Bio’s CognitOss for Chronic Osteomyelitis Earns Breakthrough Status
    • SeaSpine Launches Meridian ALIF System
    Michael Barbella, Managing Editor06.05.20
    Earlier this year, Bioventus marked the silver anniversary of a bone healing treatment system that repairs fractures via pulsed ultrasound waves. In touting the milestone, the company said its EXOGEN Ultrasound Bone Healing device has been used to treat more than 1 million patients globally, including English rugby star Olly Barkley, Norwegian World Cup and Olympic skier Magnus Moan, NFL tight end Greg Olsen, and professional hockey player Kyle Ostrow.
     
    Since its 1995 launch, EXOGEN has been prescribed by more than 10,000 physicians and sold in 15 countries. The device uses low-intensity pulsed ultrasound waves to induce micromechanical stress in fractures, amplifying the body’s natural bone repair mechanism. Studies have linked EXOGEN to an 86 percent heal rate for stubborn fractures and a 38 percent quicker healing time for fresh fractures. Bioventus claims its technology is supported by 16 Level 1 studies, but a 2016 McMaster University clinical trial found the device to be ineffective.
     
    Despite the study data disparity, EXOGEN has been a solid source of growth for Bioventus, accounting for roughly $100 million in annual worldwide sales. Part of its success can be attributed to the rising popularity of orthobiologics (a.k.a., regenerative cellular therapies), a category of biologically-based substances used to help orthopedic injuries heal more quickly. Orthobiologics are made from substances found naturally in the body, and they generally are used to improve the healing of fractures, injured muscles, tendons, and ligaments. The global orthobiologics market is forecast to grow 5.5 percent over the next seven years, driven by the world’s aging population, expanding waistlines, and increasing numbers of orthopedic conditions and musculoskeletal diseases. “Orthobiologics are revolutionizing orthopedic care,” Ignatios Papas, D.O., a non-surgical orthopedic physician in Tampa Bay, Fla., wrote in a blog last December. “Despite this, many patients don’t realize that these substances exist and can help them recover from orthopedic injuries, often without surgery.”
     
    ODT’s January/February feature, “Nature’s Way,” explores the various trends and challenges driving the global orthobiologics market. Alla Danilkovitch, Ph.D., vice president of R&D at Smith+Nephew, was among the experts interviewed for the story. Dr. Danilkovitch’s full input is provided in the following Q&A.
     
    Michael Barbella: Please discuss the current trends you see shaping the orthobiologics market.
    Alla Danilkovitch: According to market reports, the major factors attributing to the growth of the orthobiologics include increased incidences of sports injury, road accidents, and osteoarthritis. By definition, orthobiologics are substances that orthopedic surgeons use to support the healing of injured bones and soft tissues. With aging and diseases such as diabetes, the regenerative potential of the body is significantly decreased. Surgical procedures alone are not sufficient, and orthobiologics as an adjunct to surgical procedures can lead to a significant improvement of the surgical outcomes.

    Barbella: What factors are driving innovation in the orthobiologics market?
    Danilkovitch: Our understanding of the structural and functional properties of native tissue, and mechanisms of healing of injured tissue is driving development of new innovative biomaterials and cellular therapies including stem cells. Bioengineering and 3D printing of human tissues are becoming a reality.
     
    Barbella: What factors are impeding growth in the orthobiologics market? How can these challenges be overcome?
    Danilkovitch: Limited scientific and clinical evidence showing benefits of orthobiologics for specific procedures/applications. Lack of level 1 studies, long-term evidence of efficacy and lack of consensus regarding when and how to apply orthobiologics. In addition to lack of compelling evidence, high cost is becoming a factor as well. Collaborating with leading orthopedic organizations (i.e., AAOS) is one approach to generate data. It is great to see they have announced a strategic investment in the field of biologics in November 2019.
     
    Barbella: What new (orthobiologics) technologies are in the works?
    Danilkovitch: Regenerative medicine technologies including tissue engineering, biologic drugs and combinations of biologic materials with devices are new technologies in development. The main goal is to address conditions and diseases with unmet medical needs and significantly improve outcome of surgical procedures and patient’s quality of life.
     
    Barbella: Where does innovation come from in the orthobiologics market? How does Smith+Nephew stay innovative amid all the competition?
    Danilkovitch: Academia continues to be the main source of innovation, including orthobiologics. Smith+Nephew is recognizing a critical role of orthobiologics and its synergy with devices and surgical procedures. Smith+Nephew collaborates with many leading research institutions around the world. In addition, recently, Smith+Nephew formed a Biologics and Regenerative Medicine R&D team dedicated to development of innovative orthobiologic products.
     
    Barbella: How does the regulatory landscape for orthobiologics differ (if at all) from other sectors of the orthopedic market? (hips, knees,spine, etc.). How does this impact product innovation?
    Danilkovitch: The regulatory landscape for orthobiologics is very complex in comparison to other markets. Orthobiologic products can fall in different regulatory classes: tissue allografts (so-called 361 HCT/Ps, when pre-market approval is not required), 510k or PMA devices, biologic drugs or combination products. Biologic drugs or their combinations with devices are known for high development cost and a long path to market. This is one of the factors negatively affecting product innovation. Currently, there are only a few examples of orthobiologic drugs on the market.
     
    Barbella: What is the dominant orthobiologics application - spinal fusion, trauma repair, reconstructive surgery? What factors are driving growth in this particular application?
    Danilkovitch: According to market reports the major market for orthobiologics is osteoarthritis (followed by spinal fusion procedures and soft tissue injuries). Osteoarthritis already is the most common cause of disability in adults. With the global increase in the number of geriatrics and obese people, osteoarthritis is expected to be the fastest growing application segment for orthobiologics.
     
     
    Suggested For You
    GreenBone Ortho Closes 10 Million Euros Series B Funding Round GreenBone Ortho Closes 10 Million Euros Series B Funding Round
    SeaSpine to Acquire 7D Surgical for $110M SeaSpine to Acquire 7D Surgical for $110M
    Surgalign Launches New Device for Bone Formation Surgalign Launches New Device for Bone Formation
    Locate Bio’s CognitOss for Chronic Osteomyelitis Earns Breakthrough Status Locate Bio’s CognitOss for Chronic Osteomyelitis Earns Breakthrough Status
    SeaSpine Launches Meridian ALIF System SeaSpine Launches Meridian ALIF System
    Orthobiologics Market to Reach $8.7 Billion By 2027 Orthobiologics Market to Reach $8.7 Billion By 2027

    Related Online Exclusives

    • Packaging & Sterilization
      Incorporate Packaging, Sterilization Early in Product Design to Avoid Costly Mistakes

      Incorporate Packaging, Sterilization Early in Product Design to Avoid Costly Mistakes

      The specialized requirements of orthopedic products necessitate early engineering involvement.
      Michael Barbella, Managing Editor 04.13.21

    • Packaging & Sterilization
      Usability, Sustainability Becoming More Relevant in Medtech Packaging

      Usability, Sustainability Becoming More Relevant in Medtech Packaging

      Usability is no longer limited strictly to user experience.
      Michael Barbella, Managing Editor 04.07.21

    • Large Joint
      Orthopedic Solutions from Man’s Best Friend

      Orthopedic Solutions from Man’s Best Friend

      One company wants to turn an innovation from veterinary medicine into a better quality of life for human patients.
      Marc Knebel, Global Segment Head Medical Systems—Head of VESTAKEEP Europe bei Evonik Operations GmbH 02.11.21


    • Biologics
      The FDA’s Flip-Flop on Hyaluronic Acid

      The FDA’s Flip-Flop on Hyaluronic Acid

      Offering an introduction to this treatment modality for osteoarthritis, this article also looks at recent changes at FDA.
      Mike Daley, CEO, OrthogenRx 02.10.21

    • Software & Quality
      HSS, Zimmer Biomet

      HSS, Zimmer Biomet's Solution for the Episode of Orthopedic Care

      Zimmer Biomet exec Ivan Tornos provides insight into merging mymobility virtual care with HSS Orthopedic Care Pathways.
      Sam Brusco, Associate Editor 01.05.21

    • Rising to the Challenge: Q&A with AAOS Second VP Dr. Savoie

      Rising to the Challenge: Q&A with AAOS Second VP Dr. Savoie

      Orthopedic surgeons sidelined by the COVID-19 pandemic found ways to serve patients and healthcare this year as the virus spread.
      Michael Barbella, Managing Editor 12.14.20


    • Large Joint
      Teleconferencing in the OR

      Teleconferencing in the OR

      An audio/video solution enables medical device reps to still make appearances in the OR to support surgeons and healthcare providers.
      Sean Fenske, Editor-in-Chief 10.29.20

    • 3-D Printing/Additive Mfg.
      Material Advantage: How Additive Manufacturing Can Revolutionize Orthopedics

      Material Advantage: How Additive Manufacturing Can Revolutionize Orthopedics

      The technology enables innovations for both surgical tools and orthopedic implants.
      Katherine Rundell, Medical Writer, Academized 10.06.20

    • Market Conditions Ripe for Robotics Growth

      Market Conditions Ripe for Robotics Growth

      The world's aging, longer-living population and better clinical data will help drive expansion in the decade ahead.
      Michael Barbella 10.05.20


    • Machining & Tooling
      Valuating Used CNC Machines

      Valuating Used CNC Machines

      There are factors to consider to ensure the seller gets the most money from a used equipment sale.
      Michael Dunlop, Technical Writer 09.29.20

    • Robots Can Help Improve TLIF Procedure Accuracy

      Robots Can Help Improve TLIF Procedure Accuracy

      The surgery's success is dependent upon the accuracy of pedicle screw placement as determined by pre-operative planning.
      Richard V. Chua, M.D., FAANS, FACS, Northwest NeuroSpecialists PLLC and professor, Department of Neurosurgery, University of Arizona College of Medicine 09.24.20

    • 3-D Printing/Additive Mfg.
      Additive-Manufactured Orthopedic Implants Under MDR

      Additive-Manufactured Orthopedic Implants Under MDR

      Orthopedic device manufacturers have specific considerations to keep in mind when using AM under the upcoming EU regulatory system.
      Dr. Max Singh, Simon Schlagintweit, and Gregor Reischle—TÜV SÜD 08.11.20


    • Biologics
      Surgeon Creativity Shaping Orthobiologics Innovation

      Surgeon Creativity Shaping Orthobiologics Innovation

      Good relationships with surgeon customers can lead to collaborative development efforts.
      Michael Barbella, Managing Editor 05.29.20

    • Spine/Neurology
      Reducing the Footprint of Spinal Fusion

      Reducing the Footprint of Spinal Fusion

      This interview with Neo Medical’s CEO reveals the firm’s strategy to refresh the view of spinal surgery instrumentation and technology.
      Sean Fenske, Editor-in-Chief 05.29.20

    • 3-D Printing/Additive Mfg.
      5 Ways 3D Printing Will Change Medtech

      5 Ways 3D Printing Will Change Medtech

      Orthopedic-related devices such as prosthetics and instrumentation stand to benefit from the technology.
      Joshua McAlpin, Medical Industry Consultant 03.27.20


    Trending
    • Mini MRI For Hand And Wrist Imaging Can Be Used Nearly Anywhere
    • Aurora Spine Receives FDA 510(k) Clearance For Anterior Cervical Plate System
    • Incorporate Packaging, Sterilization Early In Product Design To Avoid Costly Mistakes
    • Four-Year Conformis ITotal CR Data Shows Lower Risk Of Revision
    • Mini MRI for Hand and Wrist Imaging Can Be Used Nearly Anywhere
    Breaking News
    • Biogennix Rolls Out Agilon Strip Bone Graft
    • Global Bone Tumor Ablation Devices Market to Top $111 Million by 2027
    • GreenBone Ortho Closes 10 Million Euros Series B Funding Round
    • SynerFuse, Cirtec Medical Partner to Develop Back Pain Management Device
    • New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    View Breaking News >
    CURRENT ISSUE

    March/April 2021

    • Development Options: Orthopedic Device Design
    • I, Surgical Robot
    • Printer-Friendly: An Additive Manufacturing Update
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    BIO-CAT Microbials’ OPTI-BIOME Probiotic Strain Receives FDA “Letter of No Objection” on GRAS Status
    6th Annual Dietary Supplements Regulatory Summit Scheduled for July 13
    Bunge Invests $47.5 Million in Australian Plant Proteins
    Coatings World

    Latest Breaking News From Coatings World

    Jebsen & Jessen, Innospec Sign Distribution Agreement
    VideoBite: Engineered Polymer Solutions
    Shepherd Color Unveils Bismuth Vanadate Yellow Pigment
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Medtronic Introduces Extended Infusion Set in Europe
    BioSig Launches Software Update for PURE EP Electrophysiology Platform
    Katena Acquires Ophthalmic Surgical Instrument Maker ASICO
    Contract Pharma

    Latest Breaking News From Contract Pharma

    BioVersys Gets EIB Funds to Address Antimicrobial Resistance
    Microbiologics Expands Virology Services
    ATMPS, Ori Biotech Integrate Digital Platform for Cell & Gene Therapies
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Cosmoprof Worldwide Bologna Postpones 2021 Show
    Native Launches Broad Spectrum SPF 30 Mineral Sunscreens
    Revieve Launches Skin Coach
    Happi

    Latest Breaking News From Happi

    Hallstar Beauty Names New President
    The Fragrance Foundation Announces the 2021 Awards Finalists
    Azelis Earns 'Coup de Coeur' Award at Cosmetagora 2021
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Epson SurePress reaches milestone
    Maxcess updates user interface for Fife guiding Sensor
    Bobst announces virtual packaging industry event
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    PCMC Redesigns Rx200 and Mako Clipper Wet Wipes Machines
    PFNonwovens Adding New Capabilities in Znojmo
    Russ Torres Named Group President of Kimberly-Clark North America
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Biogennix Rolls Out Agilon Strip Bone Graft
    Global Bone Tumor Ablation Devices Market to Top $111 Million by 2027
    GreenBone Ortho Closes 10 Million Euros Series B Funding Round
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    European Commission's Innovation Radar Acknowledges 3 ARMOR Innovations
    SUPERSMART Wins 'Best Publicly Funded Project Demonstrator' in 2021 OE-A Competition

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login